CD31 expression in human cancers: a pan-cancer immunohistochemical study
CD31 expression is more frequent in adenocarcinomas than in squamous cell carcinomas, with variability among cancer subtypes. Recognising CD31-positive cancers is critical to avoid misdiagnosing them as endothelial-derived tumours. The mechanisms underlying CD31 expression in cancer remain unclear and warrant further investigation.
Authors
- Akiteru Goto (ORCID: https://orcid.org/0000-0001-8776-9004)
- Masafumi Horie (ORCID: https://orcid.org/0000-0002-7726-4077)
- Daichi Maeda
- Yasufumi Omori (ORCID: https://orcid.org/0000-0001-9750-8772)
- Hiroko Ikeda (ORCID: https://orcid.org/0000-0001-9129-7433)
- Ayumi Ito
- Yukinobu Ito (ORCID: https://orcid.org/0000-0002-1774-1169)
Institutions
- Kanazawa University (JP)
- Akita University (JP)
- Kanazawa University Hospital (JP)
- Kobe University (JP)
Publication Details
- Journal
- Journal of Clinical Pathology
- Published
- 2025-05-23
- DOI
- https://doi.org/10.1136/jcp-2024-210009
- Citations
- 3
- Primary Topic
- Angiogenesis and VEGF in Cancer
- Type
- article
- Field-Weighted Citation Impact
- 2.42
Funders
- Japan Society for the Promotion of Science